Harbour Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.9K Buy
2,835
+741
+35% +$21.7K ﹤0.01% 2112
2025
Q4
$60.7K Sell
2,094
-92
-4% -$2.76K ﹤0.01% 1877
2025
Q3
$60.7K Buy
2,186
+2,143
+4,984% +$54.2K ﹤0.01% 1810
2025
Q2
$1.05K Sell
43
-71
-62% -$1.56K ﹤0.01% 3275
2025
Q1
$2.37K Hold
114
﹤0.01% 3041
2024
Q4
$2.68K Hold
114
﹤0.01% 2935
2024
Q3
$2.92K Hold
114
﹤0.01% 2809
2024
Q2
$2.68K Sell
114
-36
-24% -$909 ﹤0.01% 2721
2024
Q1
$4.31K Hold
150
﹤0.01% 2548
2023
Q4
$4.92K Sell
150
-393
-72% -$10.7K ﹤0.01% 2411
2023
Q3
$15.1K Sell
543
-371
-41% -$12.1K ﹤0.01% 1878
2023
Q2
$31.2K Sell
914
-1,833
-67% -$57.6K ﹤0.01% 1573
2023
Q1
$82.6K Sell
2,747
-271
-9% -$8.4K ﹤0.01% 1130
2022
Q4
$85.2K Sell
3,018
-611
-17% -$19.4K 0.01% 1084
2022
Q3
$114K Hold
3,629
0.01% 909
2022
Q2
$114K Buy
+3,629
New +$127K 0.01% 909
2021
Q4
$360K Sell
5,877
-15,695
-73% -$1.09M 0.02% 510
2021
Q3
$1.61M Sell
21,572
-1,539
-7% -$129K 0.05% 329
2021
Q2
$2.14M Buy
23,111
+78
+0.3% +$6.63K 0.07% 266
2021
Q1
$2.04M Buy
+23,033
New +$2.28M 0.07% 248

Other funds holding ARKG

Harbour Investments's ARKG Position: Q1 2026 in Review

Harbour Investments increased its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, buying an estimated $21.7K and bringing the position to 2,835 shares worth $74.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Harbour Investments first reported a position in ARKG in Q1 2021 and has held it in 20 quarters since. The position peaked at $2.14M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Harbour Investments held 2,835 shares of ARK Genomic Revolution ETF worth $74.9K as of Q1 2026.
  • Harbour Investments bought 741 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $21.7K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #2112 holding.
  • Harbour Investments first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's ARK Genomic Revolution ETF position peaked at $2.14M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.